Mundy G, Garrett R, Harris S, Chan J, Chen D, Rossini G, Boyce B, Zhao M, Gutierrez G
OsteoScreen, 2040 Babcock Road, San Antonio, TX 78229, USA.
Science. 1999 Dec 3;286(5446):1946-9. doi: 10.1126/science.286.5446.1946.
Osteoporosis and other diseases of bone loss are a major public health problem. Here it is shown that the statins, drugs widely used for lowering serum cholesterol, also enhance new bone formation in vitro and in rodents. This effect was associated with increased expression of the bone morphogenetic protein-2 (BMP-2) gene in bone cells. Lovastatin and simvastatin increased bone formation when injected subcutaneously over the calvaria of mice and increased cancellous bone volume when orally administered to rats. Thus, in appropriate doses, statins may have therapeutic applications for the treatment of osteoporosis.
骨质疏松症和其他骨质流失疾病是一个重大的公共卫生问题。本文表明,他汀类药物,即广泛用于降低血清胆固醇的药物,在体外和啮齿动物体内也能促进新骨形成。这种作用与骨细胞中骨形态发生蛋白-2(BMP-2)基因表达的增加有关。洛伐他汀和辛伐他汀经皮下注射到小鼠颅骨上时可增加骨形成,经口服给予大鼠时可增加松质骨体积。因此,在适当剂量下,他汀类药物可能在骨质疏松症的治疗中具有治疗应用价值。